TY - JOUR
T1 - Substrate binding and inhibition of the anion exchanger 1 transporter
AU - Capper, Michael J.
AU - Yang, Shifan
AU - Stone, Alexander C.
AU - Vatansever, Sezen
AU - Zilberg, Gregory
AU - Mathiharan, Yamuna Kalyani
AU - Habib, Raul
AU - Hutchinson, Keino
AU - Zhao, Yihan
AU - Schlessinger, Avner
AU - Mezei, Mihaly
AU - Osman, Roman
AU - Zhang, Bin
AU - Wacker, Daniel
N1 - Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer Nature America, Inc.
PY - 2023/10
Y1 - 2023/10
N2 - Anion exchanger 1 (AE1), a member of the solute carrier (SLC) family, is the primary bicarbonate transporter in erythrocytes, regulating pH levels and CO2 transport between lungs and tissues. Previous studies characterized its role in erythrocyte structure and provided insight into transport regulation. However, key questions remain regarding substrate binding and transport, mechanisms of drug inhibition and modulation by membrane components. Here we present seven cryo-EM structures in apo, bicarbonate-bound and inhibitor-bound states. These, combined with uptake and computational studies, reveal important molecular features of substrate recognition and transport, and illuminate sterol binding sites, to elucidate distinct inhibitory mechanisms of research chemicals and prescription drugs. We further probe the substrate binding site via structure-based ligand screening, identifying an AE1 inhibitor. Together, our findings provide insight into mechanisms of solute carrier transport and inhibition.
AB - Anion exchanger 1 (AE1), a member of the solute carrier (SLC) family, is the primary bicarbonate transporter in erythrocytes, regulating pH levels and CO2 transport between lungs and tissues. Previous studies characterized its role in erythrocyte structure and provided insight into transport regulation. However, key questions remain regarding substrate binding and transport, mechanisms of drug inhibition and modulation by membrane components. Here we present seven cryo-EM structures in apo, bicarbonate-bound and inhibitor-bound states. These, combined with uptake and computational studies, reveal important molecular features of substrate recognition and transport, and illuminate sterol binding sites, to elucidate distinct inhibitory mechanisms of research chemicals and prescription drugs. We further probe the substrate binding site via structure-based ligand screening, identifying an AE1 inhibitor. Together, our findings provide insight into mechanisms of solute carrier transport and inhibition.
UR - http://www.scopus.com/inward/record.url?scp=85169892699&partnerID=8YFLogxK
U2 - 10.1038/s41594-023-01085-6
DO - 10.1038/s41594-023-01085-6
M3 - Article
C2 - 37679563
AN - SCOPUS:85169892699
SN - 1545-9993
VL - 30
SP - 1495
EP - 1504
JO - Nature Structural and Molecular Biology
JF - Nature Structural and Molecular Biology
IS - 10
ER -